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BACKGROUND. Reconstruction is rarely incorporated into the decision-making
process for surgical breast cancer treatment. We examined the importance of
knowing about reconstruction to patients’ surgical decision-making for breast
cancer.
METHODS. We surveyed women aged 79 years with breast cancer (N 5 1844)
who were reported to the Detroit and Los Angeles Surveillance, Epidemiology, and
End Results (SEER) cancer registries (response rate, 77.4%). The dependent vari-
ables were 1) patients’ report of having a discussion about breast reconstruction
with their general surgeon (yes/no), 2) whether or not this discussion had an
impact on their willingness to be treated with a mastectomy (yes/no), and 3)
whether the patient received a mastectomy (yes/no). The independent variables
included age, race, education, tumor size, tumor behavior, and presence of comor-
bidities. Chi-square, Student t test, and logistic regression were used for analyses.
RESULTS. Only 33% of patients had a general surgeon discuss breast reconstruc-
tion with them during the surgical decision-making process for their cancer. Sur-
geons were significantly more likely to have this discussion with younger, more
educated patients with larger tumors. Knowing about reconstructive options sig-
nificantly increased patients’ willingness to consider a mastectomy (OR, 2.06;
P < .01). In addition, this discussion influenced surgical treatment. Patients who
discussed reconstruction with their general surgeon were 4 times more likely to
receive a mastectomy compared with those who did not (OR, 4.48; P < .01).
CONCLUSIONS. Most general surgeons do not discuss reconstruction with their
breast cancer patients before surgical treatment. When it occurs, this discussion
significantly impacts women’s treatment choice, making many more likely to
choose mastectomy. This highlights the importance of multidisciplinary care
models to facilitate an informed surgical treatment decision-making process.
Cancer 2008;112:489–94.  2007 American Cancer Society.
KEYWORDS: breast reconstruction, breast cancer, SEER, decision-making.
T here is a growing interest in understanding the surgical treatmentdecision-making process for patients with breast cancer.1–4 Sev-
eral randomized trials have demonstrated equivalent survival
between breast-conserving surgery (BCS) with radiation and mastec-
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tomy for early stage breast cancer.5,6 Although the
option of breast reconstruction has increased the
treatment choices available to breast cancer
patients,7,8 research has almost solely focused on sur-
gical treatment decision-making between BCS versus
mastectomy.9 The frequency with which general sur-
geons discuss breast reconstruction at the time of
surgical treatment decision-making is unknown.
Furthermore, it is unknown what impact this discus-
sion may have on women’s initial surgical choice
(BCS vs mastectomy). All else being equal, the option
of breast reconstruction may make mastectomy more
appealing to women who strongly value breast preser-
vation. There is virtually no information on whether
knowledge of reconstruction before initial surgical
treatment choice is associated with an increased pro-
pensity to receive mastectomy among women with
early stage breast cancer.
To address this issue, we examined the impact of
knowledge about breast reconstruction on the initial
surgical treatment decision for breast cancer. We
conducted a large population-based survey of
women recently diagnosed with breast cancer to 1)
describe the frequency with which general surgeons
discussed options of reconstruction with their breast
cancer patients at the time of initial surgical treat-
ment decision-making; and 2) describe the impact
knowing about the option of reconstruction on
patients’ choice for surgical treatment.
MATERIALS AND METHODS
Study Population
We performed a survey of a population-based sample
of 2647 women with breast cancer identified by the
Surveillance, Epidemiology and Ends Results Cancer
(SEER) Registries of the greater metropolitan areas of
Detroit and Los Angeles during a period from
December 2001 to January 2003. All patients aged 79
years and younger with ductal carcinoma in situ
(DCIS) and an approximate 20% random sample of
patients with invasive (but not metastatic) disease
were accrued into the sample during the study
period.
Women with breast cancer were identified, and
initial pathology reports were collected within 6
weeks of diagnosis for 90% of cases in Detroit and
for nearly 100% of cases in Los Angeles. Eligible sub-
jects underwent a definitive surgical procedure,
resided within the catchment area of the SEER site,
and were able to complete a questionnaire in either
English or Spanish. All Asian women and all US-born
women younger than 50 years of age diagnosed with
invasive disease in Los Angeles during our study
period were excluded because these women were al-
ready being enrolled in other studies. Women with a
diagnosis of lobular carcinoma in situ were excluded
because the natural history of and recommended
treatment for this diagnosis differs from that for
DCIS.
We prospectively selected all cases of DCIS and a
random sample of invasive cases meeting the study
criteria (oversampling African American women) each
month into the preliminary study sample (N 5 2647).
Ninety percent of all accrued cases were eligible for
the study (N 5 2382). The survey was completed by
77.4% of eligible patients (N 5 1844). Compared with
survey respondents, nonrespondents were of similar
age but were less likely to be white (69.4% vs 76.6%;
P < .001), were more likely to have stage II disease
(25.2% vs 20.4%; P 5 .034), and were more likely to
have received a mastectomy (34.7% vs 30.0%;
P 5 .021). For this analysis, we included all patients
with stage I, II, or III breast cancer and with tumors <5
cm to be consistent with guidelines of the National
Cancer Institute (NCI) and National Comprehensive
Cancer Network (NCCN) that include BCS and mas-
tectomy as options for women with these clinical pre-
sentations. We excluded approximately 10% of the
sample who had a clinical contraindication to either
BCS or mastectomy, determined through an algorithm
based on SEER clinical factors. The final sample for
analysis was 1178.
A total sampling weight was calculated for each
subject based on the probability of selection into the
study, defined by tumor behavior (DCIS vs invasive),
race/ethnicity (white, African American, other) and
site (Detroit or Los Angeles). The sampling weights
were normalized for each site to maintain the origi-
nal sample size for statistical testing.
Data Collection and Management
Physicians were notified of our intent to contact
patients. An introductory letter was sent to all poten-
tial subjects about 3 months after diagnosis followed
by a telephone call to assess eligibility. A question-
naire and gift worth $10 were mailed to all eligible
women who agreed to participate and to people who
could not be reached by telephone (approximately
14% of respondents). The Dillman method was used
to encourage response.10
SEER clinical data from the hospital-based
sources were merged with survey data for 98.2% of
cases. The study protocol was approved by the insti-
tutional review boards of the University of Michigan,
the University of Southern California, and Wayne
State University.
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Measures
The dependent variables were 1) patients’ report of
having a discussion about breast reconstruction with
a surgeon before initial surgical treatment (yes/no),
2) whether or not knowing about breast reconstruc-
tion made patients more willing to consider getting a
mastectomy (yes/no), and 3) whether the patient
received a mastectomy (yes/no). The independent
variables included patients’ self-reported age, race,
education, and comorbidities along with SEER-
reported tumor size and tumor behavior. Age was
analyzed as a continuous variable. The following
categorizations for other variables were used, race
(white, black, other), education (high school or less,
some of college or more), tumor behavior (invasive
or DCIS). Comorbidities were categorized as having
1 from a list of possible chronic conditions (em-
physema, heart disease, diabetes, hypertension,
stroke, arthritis, or other chronic condition).
Analysis
We first described the sample by using descriptive sta-
tistics to evaluate missing values and variable distri-
butions. We then described the proportion of the
sample who discussed breast reconstruction with
their general surgeon (yes/no) by the independent
variables ny using chi-square tests. Next, we regressed
patients’ reported willingness to have a mastectomy
(yes/no) on reported discussion of breast reconstruc-
tion and the rest of the patient demographic and clin-
ical factors by using logistic regression. Finally, we
regressed receipt of mastectomy (yes/no) on discus-
sion of breast reconstruction and/or willingness to
consider mastectomy, and we selected covariates by
using logistic regression. The Wald test and the likeli-
hood ratio test were used to test the significance of
individual predictive variables, and the model chi-
square statistic was applied to test the overall signifi-
cance of the model. Geographic site (Los Angeles vs
Detroit) and tumor size were controlled for in all anal-
yses. All analyses were performed with STATA soft-
ware (version 8.0; StataCorp, College Station, Tex).
RESULTS
In our analytic sample of N 5 1178, the overall mean
age was 59 years old. Of the weighted sample, 71%
were white, 20% African American, and 9% of other
race/ethnicity. Approximately two-thirds (65%) had
some college or more education. Fifteen percent
reported having a comorbid condition, defined as 1
of the above-listed conditions.
Table 1 shows the weighted study-sample charac-
teristics of patients who did and who did not discuss
breast reconstruction with their general surgeon. Only
33% of patients had a general surgeon discuss breast
reconstruction with them during the surgical deci-
sion-making process for their cancer. Patients who
discussed reconstruction with their surgeon were sig-
nificantly younger than those who did not (mean age
56 vs 61 years, respectively; P < .001), had larger mean
tumor sizes (2.3 cm vs 1.9 cm, respectively; P 5 .02),
and were more educated (41.9% of those with some
college or more vs 30.0% of those with high school or
less; P < .001). No differences were noted by patient
race, tumor behavior, or comorbid conditions.
Table 2 shows the associations between knowing
about breast reconstruction and patients’ self-
reported willingness to think about having a mastec-
tomy while controlling for selected demographic and
clinical covariates. Patients who discussed breast
reconstruction with their surgeon were significantly
more willing to consider having a mastectomy com-
pared with those who did not have this discussion
(OR, 2.06; P < .001). We tested the interactions
between patient age and discussing reconstruction on
willingness to have a mastectomy, and these interac-
tion terms were not significant in the model. Table 3
shows the association between patient report of
reconstruction discussion and receipt of mastectomy
while controlling for important covariates. Patients
who discussed reconstruction were more than 4 times
TABLE 1
Characteristics of the Study Sample (N 5 1178)
Discussed breast
reconstruction with surgeon*
Variable Yes, N 5 384 No, N 5 794 P






High school or less 30.0 70.0
Some college or more 41.9 58.1







DCIS indicates ductal carcinoma in situ.
* Student t test.
y Chi-square.
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more likely to receive a mastectomy (OR, 4.48;
P < .001).
DISCUSSION
In this large population-based study, we found that
only 33% of patients eligible for mastectomy or BCS
reported that their general surgeon discussed breast
reconstruction with them during the surgical deci-
sion-making process. Younger patients with higher
levels of education were more likely to report having
this discussion with their surgeon than their counter-
parts. Perhaps most importantly, we found that
having a discussion about reconstructive options sig-
nificantly increased patients’ willingness to consider
a mastectomy. As would be expected, having this
discussion strongly influenced surgical treatment
choices; those who reported having had a discussion
about reconstruction were more than 4 times more
likely to receive a mastectomy compared with those
who did not.
These results suggest that the option of breast
reconstruction is intimately tied to patient’s choice of
surgery and significantly increases the likelihood that
a patient eligible for both options will choose mas-
tectomy. The surgical treatment of early stage breast
cancer is a preference-sensitive decision that has his-
torically focused on the surgical options of BCS and
mastectomy.9,11 Our findings indicate that this tradi-
tional surgical decision-making paradigm for breast
cancer may need to be adapted to include the option
of reconstruction during the initial surgical treatment
discussion. Women eligible for reconstruction at the
time of the mastectomy (immediate reconstruction)
are those with early stage disease (stage I or II) who
are at a low risk for postmastectomy radiation. And,
compared with delayed procedures, tissue expander/
implant or autogenous tissue reconstructions per-
formed at the time of the mastectomy are associated
with better esthetic and psychological outcomes.12
These results underscore the importance of
informing patients about the option of breast recon-
struction before initial surgical choice. Others have
shown that multidisciplinary cancer care, including
consultations with medical and/or radiation oncolo-
gists before surgery, influences the ultimate surgical
choice.13,14 In addition, Hawley et al. showed that a
surgeon’s propensity to refer patients with breast
cancer to a plastic surgeon before surgical can-
cer treatment explained a substantial amount of
between-surgeon variation in use of reconstruction.15
Our results augment this research by suggesting that
discussion of reconstruction before surgery will also
impact initial surgical treatment decision-making.
Taken together, this research suggests that patients
should be informed of all options to be educated
consumers of healthcare and to ensure maximal
breast cancer treatment decision quality.
The reason for our finding that younger, more
highly educated patients more often reported a dis-
cussion of breast reconstruction is unclear. Breast re-
construction occurs more commonly among younger
women,16 but whether this is driven by patient prefer-
ence, physician bias, or clinical contraindications is
unknown. In the era of sentinel lymph node biopsy,
BCS in the lymph node-negative patient is an outpa-
tient surgical procedure that is associated with a con-
siderably more rapid return to full activity than a
mastectomy with reconstruction. Our work has pre-
viously shown that interruption of the activities of
TABLE 2
Multivariate Logistic Regression of Breast Cancer Patients’ Willingness
to Have a Mastectomy
Variable OR (95% CI) P
Discussed breast reconstruction with
general surgeon (yes/no) 2.06 (1.40, 3.03) <.001
Age 0.95 (0.93, 0.97) <.001
Race/Ethnicity
White — —
Black 0.45 (0.27, 0.71) .003
Other 0.72 (0.36, 1.45) .362
Education
Some high school or graduate — —
Some college or graduate 0.92 (0.61, 1.40) .698
Comorbidities (yes/no) 0.86 (0.45, 1.69) .664
The model controlled for geographic location (Detroit, Los Angeles), tumor size, and tumor behavior.
TABLE 3
Multivariate Logistic Regression of Receipt of Mastectomy
Variable OR (95% CI) P
Discussed breast reconstruction with
general surgeon (yes/no) 4.48 (3.31, 6.06) <.001
Age 1.01 (0.99, 1.02) .40
Race/Ethnicity
White — —
Black 1.46 (1.03, 2.08) .04
Other 2.15 (1.33, 3.47) .002
Education
Some high school or graduate — —
Some college or graduate 0.53 (0.39, 0.72) <.001
Comorbidities 1.36 (0.80, 1.48) .585
The model controlled for geographic location (Detroit, Los Angeles), tumor size, and tumor behavior.
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daily life is a more important factor in treatment deci-
sions for older women than their younger counter-
parts,17 and this may in part account for the relation
between age and reconstruction observed in this and
other studies. In addition, patients with higher levels
of education may take more initiative to be well-
informed consumers of healthcare and, therefore,
possibly initiate this discussion. Nevertheless, our
results suggest a need for comprehensive breast can-
cer treatment decision aids, including information on
initial surgery and other treatment options such as
reconstruction. These tools need to be able to convey
information to patients with different demographic
and clinical characteristics.
Limitations
Our findings should be interpreted in the context of
some limitations. These results are limited to 2 met-
ropolitan areas, Detroit and Los Angeles, and may
not reflect national trends in breast cancer care.
However, the large racially and ethnically diverse
population-based patient samples and the high
response rate suggest that we have a sample that is
well representative of breast cancer patients in the
US. We were also limited by the self-reported nature
of our outcome variables, which may be subject to
recall bias. A related issue is that were not able to
determine whether reconstruction discussions were
initiated by patients or surgeons. In some cases, sur-
geons might have appropriately tailored the discus-
sion of treatment options on the bases of the
patients stated preference for BCS and lack of inter-
est in mastectomy options. Lastly, the study was nec-
essarily retrospective in design. Patients’ recall of
their encounters with clinicians may vary because of
the passage of time or be influenced by their treat-
ment experiences.
Implications
Our results have important implications for patient
care and policy. First, our findings suggest that the
underlying paradigm of informed breast cancer
treatment decision-making may need to change to
include mastectomy with the option of reconstruc-
tion, especially for patients who have clinical con-
traindications to BCS, those who express a
preference for treatment with mastectomy, and
those who are uncertain about their treatment
choice. To achieve this shift, general surgeons
should consider incorporating discussions of recon-
struction or referring patients to plastic surgeons
before the patient’s surgical decision. Our prior
research in this area found that only 24% of general
surgeons report referring 75% or more of their
mastectomy patients to plastic surgeons as part of
their standard practice.18 These data suggest that
higher rates of referral could have a measurable
impact on surgical treatment outcomes. In addition,
efforts to improve surgeons’ propensity to discuss
reconstruction or refer to plastic surgeons need to
emphasize the importance of doing so across all
types of patients, regardless of patient demographic
or clinical factors. Finally, decision tools that include
accurate information about all treatment options
will improve the quality of breast cancer treatment
decision-making. Such decision tools could also sti-
mulate patients to raise the issue of breast recon-
struction with their general surgeon.
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